ClinicalTrials.govpublic full text
Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia
sickle cell anemia, beta thalassemia, myeloid chimerism, lymphoid cells, myeloid cells, donor leukocyte engraftment, non-myeloablative conditioning, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 897552
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.